Dianthus Therapeutics

Unlocking the full potential of complement therapeutics through the power of selectivity.

[Dianthus Therapeutics @dianthustx]

Meet Indrajit! When he’s not volunteering at non-profit organizations in service of underprivileged children in third world countries, you can find him running, gardening or training to be a scuba diver.
We’re honored to have you on our team, Indrajit!
#OurTeam #GrowWithUs

[Dianthus Therapeutics @dianthustx]

Dianthus is pleased to share that the first healthy volunteers have been dosed in a Phase 1 clinical trial of our lead #ComplementTherapy, DNTH103, a next-generation selective inhibitor of the classical complement pathway. Learn more: https://t.co/845WSXussC

[Dianthus Therapeutics @dianthustx]

Our new Careers page is LIVE! Learn more about our people, values, benefits and how you can #GrowWithUs at Dianthus. Visit https://t.co/p7HvPBkj8A to find your next career.

#BiotechJobs #NowHiring #BostonJobs #NYCJobs

[Dianthus Therapeutics @dianthustx]

Happy Thanksgiving from team Dianthus! We are especially thankful for our amazing employees, investors, and board for their work and support this year.

[Dianthus Therapeutics @dianthustx]

If you’re at the @Jefferies Healthcare Conference next week, keep an eye out for our very own Marino Garcia (CEO) and Ryan Savitz (CFO). Reach out if you’re interested in learning more about our fit-for-purpose development strategy in #ComplementTherapeutics.

[Dianthus Therapeutics @dianthustx]

Last month, we were thrilled to unveil the new Dianthus company #values to our full team and hold thoughtful discussions around building a company #culture where we can #CultivateTrust, #DigDeep, #GrowTogether & #ReachHigher.

[Dianthus Therapeutics @dianthustx]

Our team showed off their mad skills this week.
#Halloween #Connection #OurTeam

[Dianthus Therapeutics @dianthustx]

We are thrilled to unveil our new office located in Times Square! Our dual HQs in NYC and Waltham, MA – combined with our hybrid-remote working model supporting teams across 10 states – allow us to recruit the best talent nationwide. Come #GrowWithUs – we’re #hiring!

[Dianthus Therapeutics @dianthustx]

#DefiningDianthus: Building on the legacy and meaning behind our company name, our values tell the story of how we create a workplace where everyone can thrive. Come #GrowWithUs. Visit https://t.co/fr6LIB7YMg to find your next career.

[Dianthus Therapeutics @dianthustx]

Why "Dianthus"? Dianthus is a flower that resembles the elegant crystalline structure of the C1 complex targeted by our lead complement therapy candidate, DNTH103. Learn more about who we are here: https://t.co/fr6LIB7YMg #biotech #RareDisease

[Dianthus Therapeutics @dianthustx]

Thank you to Glenda Thomas for taking the time to share your story with our team and for dedicating your time for the advocacy of patients with #MyastheniaGravis and #RareDiseases. To learn more about Glenda’s story, click here: https://t.co/60Ny7fy7j1

[Dianthus Therapeutics @dianthustx]

Last week, we were thrilled to gather our teams at our 2022 Fall Company Offsite! As Dianthus grows, we are intentionally building a team that is united by a shared commitment to our people and our mission - so we can create a workplace where everyone thrives. Come grow with us.

[Dianthus Therapeutics @dianthustx]

Are you an executive leader with a passion for shaping the future of #autoimmune disease therapies? We’re #hiring a Head of Research & Innovation to lead our discovery and pipeline strategies. Learn more here: https://t.co/ZaaGI7MNXs #BiotechJobs

[Dianthus Therapeutics @dianthustx]

Are you a senior legal strategist looking for the opportunity to make a lasting impact on a leading #biotech company? We are #hiring! Apply for our #GeneralCounsel position at: https://t.co/XZDlmdiGfW #BiotechJobs

[Dianthus Therapeutics @dianthustx]

We are thrilled to welcome Scott Nogi as our Head of Operations! Scott joins Dianthus with 20+ years of experience in operations management & business development. Visit https://t.co/fr6LIB7YMg to learn more about our #DrugDevelopment experts & next-gen #ComplementTherapeutics.

[Dianthus Therapeutics @dianthustx]

We are excited to expand our leadership team with the appointments of Ryan Savitz as CFO, Polly Hanff as Head of Quality, and Judson Taylor as Head of Technical Operations. Visit https://t.co/fr6LIB7YMg for more. #ComplementTherapeutics #BiotechNews

[BioSpace @biospace]

@dianthustx launched Tuesday with $100 million in Series A financing led by 5AM Ventures, Avidity Partners and Fidelity Research and Management.
#DianthusTherapeutics #AutoimmuneDiseases #BioSpace
https://t.co/u6DSP5I2H1

[BioWorld @BioWorld]

@dianthustx blossoms with $100M series A round to target complement system https://t.co/2GJrmU40Ku #biotech #pharma

[Jeff Cranmer @jeff_cranmer]

In @BioCentury's latest Emerging Company Profile, @BioBonanos reports on @DianthusTx, which has raised $121M for engineered complement mAbs. The company is backed by the family office of Lonnie Moulder, former CEO of Tesaro. Details: https://t.co/v5mcOpVN3L

[Endpoints News @endpts]

Dianthus Therapeutics is taking the wraps off a $100 million Series A as it explains its mission.

https://t.co/VuNpy4VY9r